Related content

Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup

By Hauben E.I.   Weeden S.   Pringle J.   Van Marck E.A.   Hogendoorn P.C.W.   on behalf of the European Osteosarcoma Intergroup  

European Journal of Cancer, Vol. 38, Iss. 9, 2002-06 ,pp. : 1218-1225

Elsevier

Access to resources Recommend Favorite

A comment and update on ''Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup''

By Bacci G.   Ferrari S.   Bertoni F.   Longhi A.   Bacchini P.   Giacomini S.   Forni C.  

European Journal of Cancer, Vol. 39, Iss. 4, 2003-03 ,pp. : 548-549

Elsevier

Access to resources Recommend Favorite

Interferon- as the only adjuvant treatment in high-grade osteosarcoma: Long term results of the Karolinska Hospital series

By Müller Christoph   Smeland Sigbjørn   Bauer Henrik   Sæter Gunnar   Strander Hans  

Acta Oncologica, Vol. 44, Iss. 5, 2005-07 ,pp. : 475-480

Informa Healthcare

Access to resources Recommend Favorite

Meta-analysis of limb salvage versus amputation for treating high-grade and localized osteosarcoma in patients with pathological fracture

By              

Experimental and Therapeutic Medicine, Vol. 4, Iss. 5, 2012-01 ,pp. : 889-894

Spandidos Publications

Access to resources Recommend Favorite

High-grade maxillofacial osteosarcoma: evolving strategies for a curable cancer

By Rosenthal M.A.   Mougos S.   Wiesenfeld D.  

Oral Oncology, Vol. 39, Iss. 4, 2003-06 ,pp. : 402-404

Elsevier

Access to resources Recommend Favorite